Evidence map›Paper›PMID 21145862›Full record

Trial reportJournal of hepatology2011

Predictors and effects of alcohol use on liver function among young HCV-infected injection drug users in a behavioral intervention.

Lydia N Drumright, Holly Hagan, David L Thomas, Mary H Latka, Elizabeth T Golub, Richard S Garfein, John D Clapp, Jennifer V Campbell, Sebastian Bonner, Farzana Kapadia and 2 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of hepatology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 5 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 5 syntheses or guidelines pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Efficacy of Psychosocial Interventions in Inducing and Maintaining Alcohol Abstinence in Patients With Chronic Liver Disease: A Systematic Review.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2016
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Article
  9. Review
  10. Diagnosis and Management of Alcohol Use Disorder in Patients with Liver Disease: Lights and Shadows.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2020
    Review
  11. Opioid epidemic and liver disease.JHEP reports : innovation in hepatology · 2019
    Review
  12. Integrating Care for Patients With Chronic Liver Disease and Mental Health and Substance Use Disorders.Federal practitioner : for the health care professionals of the VA, DoD, and PHS · 2018
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 1 country.

Lydia N DrumrightUniversity of California, San Diego, Department of Medicine, La Jolla, CA, USA.
Holly Hagan
David L Thomas
Mary H Latka
Elizabeth T Golub
Richard S Garfein
John D Clapp
Jennifer V Campbell
Sebastian Bonner
Farzana Kapadia
Thelma King Thiel
Steffanie A Strathdee
New York Academy of Medicine · USUniversity of California, San Diego · USJohns Hopkins Medicine · USHepatitis B Foundation · USNational Development and Research Institutes · USPublic Health – Seattle & King County · USSan Diego State University · US

Funding

Reduce Transmission Risks &Improve HCV Treatment AccessR01DA014499 · NIDA · JOHNS HOPKINS UNIVERSITY · PI STRATHDEE, STEFFANIE A · 2001 to 2004
$3.8M
NIDA NIH HHS R01 DA014499NIDA NIH HHS R01 DA14499
6 · The paper itself

Abstract

BACKGROUND &

aimsHepatitis C virus (HCV) screening can provide opportunities to reduce disease progression through counseling against alcohol use, but empirical data on this issue are sparse. We determined the efficacy of a behavioral intervention in reducing alcohol use among young, HCV-infected injection drug users (IDUs) (n=355) and assessed whether changes in liver enzymes were associated with changes in alcohol consumption.

methodsBoth the intervention and attention-control groups were counseled to avoid alcohol use, but the intervention group received enhanced counseling. Logistic regression, ANOVA, and continuous time Markov models were used to identify factors associated with alcohol use, changes in mean ALT and AST levels, and change in alcohol use post-intervention.

resultsSix months post-intervention, alcohol abstinence increased 22.7% in both groups, with no difference by intervention arm. Transition from alcohol use to abstinence was associated with a decrease in liver enzymes, with a marginally greater decrease in the intervention group (p=0.05 for ALT; p=0.06 for AST). In multivariate Markov models, those who used marijuana transitioned from alcohol abstinence to consumption more rapidly than non-users (RR=3.11); those who were homeless transitioned more slowly to alcohol abstinence (RR=0.47); and those who had ever received a clinical diagnosis of liver disease transitioned more rapidly to abstinence (RR=1.88).

conclusionsAlthough, behavioral counseling to reduce alcohol consumption among HCV-infected IDUs had a modest effect, reductions in alcohol consumption were associated with marked improvements in liver function. Interventions to reduce alcohol use among HCV-infected IDUs may benefit from being integrated into clinical care and monitoring of HCV infection.

Indexed as

Behavior TherapyTemperanceAdolescentAdultAlanine TransaminaseAlcohol DrinkingAspartate AminotransferasesFemaleHepatitis C, ChronicHumansLiver Function TestsLogistic ModelsMaleMarkov ChainsSubstance Abuse, IntravenousYoung AdultAlanine TransaminaseAspartate Aminotransferases

Identifiers

PMID21145862
PMCPMC3094600
OpenAlexW2092513155

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.